116 related articles for article (PubMed ID: 38563150)
1. Exploring the immune-modulating properties of boswellic acid in experimental autoimmune encephalomyelitis.
Shadab A; Abbasi-Kolli M; Yazdanpanah E; Esmaeili SA; Baharlou R; Yousefi B; Haghmorad D
APMIS; 2024 Jun; 132(6):452-464. PubMed ID: 38563150
[TBL] [Abstract][Full Text] [Related]
2. The effect of 1, 25(OH)2 D3 (calcitriol) alone and in combination with all-trans retinoic acid on ROR-γt, IL-17, TGF-β, and FOXP3 gene expression in experimental autoimmune encephalomyelitis.
Parastouei K; Mirshafiey A; Eshraghian MR; Shiri-Shahsavar MR; Solaymani-Mohammadi F; Chahardoli R; Alvandi E; Saboor-Yaraghi AA
Nutr Neurosci; 2018 Apr; 21(3):210-218. PubMed ID: 27996890
[TBL] [Abstract][Full Text] [Related]
3. CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Shahid M; Al-Mazroua HA; As Sobeai HM; Alasmari AF; Alanazi MM; Alhamed AS; Aldossari AA; Attia SM
Cell Immunol; 2022 Sep; 379():104580. PubMed ID: 35872534
[TBL] [Abstract][Full Text] [Related]
4. Carvacrol ameliorates experimental autoimmune encephalomyelitis through modulating pro- and anti-inflammatory cytokines.
Mahmoodi M; Amiri H; Ayoobi F; Rahmani M; Taghipour Z; Ghavamabadi RT; Jafarzadeh A; Sankian M
Life Sci; 2019 Feb; 219():257-263. PubMed ID: 30472298
[TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D
Haghmorad D; Yazdanpanah E; Jadid Tavaf M; Zargarani S; Soltanmohammadi A; Mahmoudi MB; Mahmoudi M
Neurol Res; 2019 Oct; 41(10):943-957. PubMed ID: 31402771
[TBL] [Abstract][Full Text] [Related]
6. IFN-γ-Primed hUCMSCs Significantly Reduced Inflammation
Ling X; Wang T; Han C; Wang P; Liu X; Zheng C; Bi J; Zhou X
Front Immunol; 2022; 13():835345. PubMed ID: 35300342
[TBL] [Abstract][Full Text] [Related]
7. Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance.
Aldossari AA; Assiri MA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Albekairi TH; Alomar HA; Al-Mazroua HA; Almanaa TN; Al-Hamamah MA; Alwetaid MY; Ahmad SF
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894952
[TBL] [Abstract][Full Text] [Related]
8. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
9. Daphnetin alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating Th2 and regulatory T cells.
Soltanmohammadi A; Tavaf MJ; Zargarani S; Yazdanpanah E; Sadighi-Moghaddam B; Yousefi B; Sameni HR; Haghmorad D
Acta Neurobiol Exp (Wars); 2022; 82(3):273-283. PubMed ID: 36214710
[TBL] [Abstract][Full Text] [Related]
10. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone improves experimental autoimmune encephalomyelitis by regulating both pro-inflammatory and anti-inflammatory cytokines.
Kazemi R; Yazdanpanah E; Esmaeili SA; Yousefi B; Baharlou R; Haghmorad D
Mol Biol Rep; 2024 Feb; 51(1):256. PubMed ID: 38302802
[TBL] [Abstract][Full Text] [Related]
13. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
[TBL] [Abstract][Full Text] [Related]
15. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
[TBL] [Abstract][Full Text] [Related]
16. The fatty acid-binding protein (FABP) decreases the clinical signs and modulates immune responses in a mouse model of experimental autoimmune encephalomyelitis (EAE).
Hajizadeh M; Saboor-Yaraghi AA; Meamar AR; Khoshmirsafa M; Razmjou E; Sadeghipour A; Bagheri Y; Sadeghi F; Jalallou N; Kazemi MH; Salari AA; Falak R
Int Immunopharmacol; 2021 Jul; 96():107756. PubMed ID: 33993100
[TBL] [Abstract][Full Text] [Related]
17. Medium-dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice.
Haghmorad D; Salehipour Z; Nosratabadi R; Rastin M; Kokhaei P; Mahmoudi MB; Amini AA; Mahmoudi M
J Immunotoxicol; 2016 Nov; 13(6):885-896. PubMed ID: 27602995
[TBL] [Abstract][Full Text] [Related]
18. Tehranolid and Artemisinin Effects on Ameliorating Experimental Autoimmune Encephalomyelitis by Modulating Inflammation and Remyelination.
Salehi N; Nourbakhsh M; Noori S; Rezaeizadeh H; Zarghi A
Mol Neurobiol; 2023 Oct; 60(10):5975-5986. PubMed ID: 37391648
[TBL] [Abstract][Full Text] [Related]
19. Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells.
Tavaf MJ; Soltanmohammadi A; Zargarani S; Yazdanpanah E; Sadighimoghaddam B; Yousefi B; Sameni HR; Haghmorad D
Immun Inflamm Dis; 2023 Jan; 11(1):e766. PubMed ID: 36705421
[TBL] [Abstract][Full Text] [Related]
20. STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance.
Gharibi T; Barpour N; Hosseini A; Mohammadzadeh A; Marofi F; Ebrahimi-Kalan A; Nejati-Koshki K; Abdollahpour-Alitappeh M; Safaei S; Baghbani E; Baradaran B
Int Immunopharmacol; 2023 Jun; 119():110160. PubMed ID: 37080068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
